- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
GOP Congress Moves Veto-Bait Bill on Healthcare
In command and ready for a fight, Republicans ignored a White House veto threat and advanced a bill in Congress that would curb President Barack Obama's healthcare overhaul by redefining full-time work as 40 hours a week.
In command and ready for a fight, defiant Republicans ignored a White House veto threat and advanced a bill in Congress Thursday that would curb President Barack Obama’s healthcare overhaul by redefining full-time work as 40 hours a week.
The House approved legislation narrowing the definition of full-time workers who must be offered employer-provided healthcare from those working 30 hours weekly to a 40-hour minimum. The vote was a mostly party-line 252-172—short of the 290 needed, assuming all members voted, for the two-thirds majority required to override a veto.
House Minority Leader Nancy Pelosi (D-Calif.) said Democrats would sustain Mr Obama’s veto on the bill.
Read more: http://wapo.st/1zZZdho
Source: The Washington Post
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Study Links COVID-19 Pandemic to Rise in Neoadjuvant Chemotherapy for Ovarian Cancer in US
April 17th 2024There was greater use of neoadjuvant chemotherapy among US patients with ovarian cancer (OC) during the COVID-19 pandemic to reduce potential COVID-19 exposure and cancer treatment-related complications.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
